| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/14/2002 | EP1230367A1 19 human secreted proteins |
| 08/14/2002 | EP1230360A2 15 human secreted proteins |
| 08/14/2002 | EP1230349A2 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 08/14/2002 | EP1230342A1 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 08/14/2002 | EP1230264A1 Therapeutic compositions and methods for treating disease states with mutant forms of myeloid progenitor inhibitory factor-2 (mpif-2) |
| 08/14/2002 | EP1230255A1 25 human secreted proteins |
| 08/14/2002 | EP1230236A1 Compound with growth hormone releasing properties |
| 08/14/2002 | EP1230227A1 Benzoxa-and benzothiazolyl sulfamates and their use as steroid sulfatase inhibitors |
| 08/14/2002 | EP1230222A1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 08/14/2002 | EP1230215A1 Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 08/14/2002 | EP1230214A2 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 08/14/2002 | EP1229934A2 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 08/14/2002 | EP1229917A1 Pharmaceutical compositions and preparations for treatment of metabolic bone disease |
| 08/14/2002 | EP1229915A1 Protease inhibitors |
| 08/14/2002 | EP1229914A1 Protease inhibitors |
| 08/14/2002 | EP1229912A1 Protease inhibitors |
| 08/14/2002 | EP1229911A1 Protease inhibitors |
| 08/14/2002 | EP1229910A1 Integrin receptor antagonists |
| 08/14/2002 | EP0988038B1 (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation |
| 08/14/2002 | EP0973519B1 Inclusion complexes in aqueous solution |
| 08/14/2002 | EP0937076B1 Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 08/14/2002 | EP0906262B1 Colchicine-skeleton compounds, their use as medicaments and compositions containing them |
| 08/14/2002 | EP0892642B1 Use in a composition of an extract of at least one labiate of the genus rosmarinarus, cultured in vitro |
| 08/14/2002 | EP0814823B1 Polyphenol fractions of tea, the use thereof and formulations containing them |
| 08/14/2002 | EP0807111B1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same |
| 08/14/2002 | EP0531425B1 Combination of IGF-I and TGF-beta for bone regeneration |
| 08/14/2002 | DE10105989A1 Substituierte Oxazolidinone und ihre Verwendung Substituted oxazolidinones and their use |
| 08/14/2002 | CN1364168A Hydrochloride of fused-heterocycle compound |
| 08/14/2002 | CN1364155A N-Cyanomethyl amides as protease inhibitors |
| 08/14/2002 | CN1364090A Medicinal compositions containing anti-Fas antibody |
| 08/14/2002 | CN1364085A Use of phyllanthus for treating chronically inflammatory and fibrotic processes |
| 08/14/2002 | CN1364082A Procyanidin oligomers inhibiting matrix metalloproteinases and medicine having same effective composition |
| 08/14/2002 | CN1363387A Exterior-applied medicine for treating hyperosteogeny and lumbar intervertebral disk protrusion |
| 08/14/2002 | CN1363380A Medicine for treating xerosis syndrome and its preparing process |
| 08/14/2002 | CN1363364A Chinese medicine for treating lumbar intervertebral disk protrusion |
| 08/14/2002 | CN1363359A Jinma capsule for building up body and relieving pain |
| 08/14/2002 | CN1363356A Multifunctional plaster |
| 08/14/2002 | CN1363354A Chinese patent medicine for treating lumbocrural pain and Woman's wind sieases during pregnancy and post partum |
| 08/14/2002 | CN1363326A Nano method for making bone joint stronger and its preparing process |
| 08/14/2002 | CN1363297A Nano medicine 'Anluotong' and its preparing process |
| 08/14/2002 | CN1363283A Beetoxin injection and its preparing process |
| 08/14/2002 | CN1363272A Method for fixing Chinese-medicinal bone-setting paper |
| 08/14/2002 | CN1088999C Process for preparing medicine to cure rheumatoid arthritis |
| 08/14/2002 | CA2371487A1 Tricyclic sulfonamide matrix metalloproteinase inhibitors |
| 08/14/2002 | CA2371481A1 Sulfonamide matrix metalloproteinase inhibitors |
| 08/14/2002 | CA2371480A1 Biphenyl sulfonamides useful as matrix metalloproteinase inhibitors |
| 08/13/2002 | US6433202 Antiinflammatory agents |
| 08/13/2002 | US6433171 Dipeptide derivatives |
| 08/13/2002 | US6433165 Chemokine receptor antagonists and methods of use therefor |
| 08/13/2002 | US6433021 Antiinflammatory agents; mast cell stabilizers |
| 08/13/2002 | US6433009 Treatment of autoimmune, cardiovascular, nervous system, gastrointestinal, respiratory system, and viral disorders; antidiabetic, antiarthritic, antiinflammatory and antidepressant agents |
| 08/13/2002 | US6433008 Treating parkinson*s, alzheimer*s, autoimmune and rheumatic diseases; human immunodeficiency virus (hiv) dementia, and inflammation |
| 08/13/2002 | US6433005 Selective cox ii inhibitor |
| 08/13/2002 | US6432988 2-arylalkylthio -imidazoles, 2-arylalkenyl -thio -imidazoles and 2-arylalkinyl -thio -imidazoles as anti -inflammatory substances and substances inhibiting the release of cytokine |
| 08/13/2002 | US6432982 Benzothiophenes, and formulations and methods using same |
| 08/13/2002 | US6432973 Polyoxyethylated hydroxyesters of rapamycin useful in inducing immunosuppression and in the treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, and vascular disease. |
| 08/13/2002 | US6432962 Antiinflammatory agents |
| 08/13/2002 | US6432949 Amide derivatives useful as inhibitors of the production of cytokines |
| 08/13/2002 | US6432947 N-heterocyclic derivatives as NOS inhibitors |
| 08/13/2002 | US6432945 Dipeptide derivatives |
| 08/13/2002 | US6432940 Uses for androst-5-ene-3β, 17β-diol |
| 08/13/2002 | US6432937 Treatment for joint inflammation |
| 08/13/2002 | US6432931 Compositions and methods for inhibiting bone resorption |
| 08/13/2002 | US6432929 Cartilage enhancing food supplements and methods of preparing the same |
| 08/13/2002 | US6432922 Antitumor agents; angiogenesis inhibitors |
| 08/13/2002 | US6432659 Motor proteins and methods for their use |
| 08/13/2002 | US6432445 Oil-free; bioavailability; useful as immunosuppressive agents, parasiticides, and agents for the reversal of multi-drug resistance |
| 08/13/2002 | CA2328851C Humanized immunoglobulins and their production and use |
| 08/12/2002 | CA2369967A1 Methods of treating nuclear factor-kappa b mediated diseases and disorders |
| 08/08/2002 | WO2002061110A2 Nucleic acid derivatives |
| 08/08/2002 | WO2002061052A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 08/08/2002 | WO2002060900A2 Antagonists of mcp-1 function and methods of use thereof |
| 08/08/2002 | WO2002060899A1 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them |
| 08/08/2002 | WO2002060898A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060897A2 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 08/08/2002 | WO2002060896A1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060895A1 Diazocine derivatives and their use as tryptase inhibitors |
| 08/08/2002 | WO2002060894A2 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | WO2002060890A1 Novel physiologically active substances |
| 08/08/2002 | WO2002060875A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060859A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/08/2002 | WO2002060858A1 Novel compound having maillard reaction inhibitory activity |
| 08/08/2002 | WO2002060535A1 Method of treating inflammatory conditions by inhibiting cytosolic phospholipase a¿2? |
| 08/08/2002 | WO2002060492A1 Methods of inhibiting kinases |
| 08/08/2002 | WO2002060480A1 Methods for treating or preventing skin disorders using cd2-binding agents |
| 08/08/2002 | WO2002060464A2 Compositions containing an active fraction isolated from hedyotis diffusae and methods of use |
| 08/08/2002 | WO2002060456A1 Treatment of angiogenesis-dependent conditions with dextrin sulphates |
| 08/08/2002 | WO2002060445A1 Kappa opioid receptor ligands |
| 08/08/2002 | WO2002060438A1 Substituted indoles and their use as integrin antagonists |
| 08/08/2002 | WO2002060431A1 Remedies/preventives for inflammatory diseases |
| 08/08/2002 | WO2002060393A2 Proteoglycan compositions for treatment of inflammatory conditions |
| 08/08/2002 | WO2002060386A2 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF IλB KINASE (IKK) |
| 08/08/2002 | WO2002060382A2 Novel compounds and uses thereof |
| 08/08/2002 | WO2002060378A2 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 08/08/2002 | WO2002040505A3 Dibenzoxazepine alpha v integrin receptor antagonist |
| 08/08/2002 | WO2002034716A3 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 08/08/2002 | WO2002032900A3 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | WO2002028165A3 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 08/08/2002 | WO2002020762A3 Tnf receptor-like molecules and uses thereof |
| 08/08/2002 | WO2002011747A3 Transglutaminase for inhibiting angiogenesis |